Regional atrophy of transcallosal prefrontal connections in cognitively normal APOE ϵ4 carriers

To investigate the possible effect of the APOE ϵ4 allele on age‐related regional volume loss within the corpus callosum (CC) in healthy ϵ4 allele carriers compared with noncarriers.

[1]  Kaarin J Anstey,et al.  Total and regional gray matter volume is not related to APOE*E4 status in a community sample of middle-aged individuals. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[2]  Anders M. Fjell,et al.  Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E ɛ4 , 2008, Neurobiology of Aging.

[3]  Chiara Nosarti,et al.  Growth of the corpus callosum in adolescents born preterm. , 2007, Archives of pediatrics & adolescent medicine.

[4]  Timothy Edward John Behrens,et al.  Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. , 2007, Brain : a journal of neurology.

[5]  Andrew J. Saykin,et al.  Regional brain atrophy in cognitively intact adults with a single APOE ε4 allele , 2006, Neurology.

[6]  Heidi Johansen-Berg,et al.  Functional anatomy of interhemispheric cortical connections in the human brain , 2006, Journal of anatomy.

[7]  H. Wishart.  Increased brain activation during working memory in cognitively intact adults with the APOE ε4 allele , 2006 .

[8]  T. Asada,et al.  Age-related degeneration of corpus callosum measured with diffusion tensor imaging , 2006, NeuroImage.

[9]  N. Schuff,et al.  Age effects on atrophy rates of entorhinal cortex and hippocampus , 2006, Neurobiology of Aging.

[10]  L Nyberg,et al.  Altered brain white matter integrity in healthy carriers of the APOE ε4 allele , 2006, Neurology.

[11]  John S. Allen,et al.  Normal neuroanatomical variation due to age: The major lobes and a parcellation of the temporal region , 2005, Neurobiology of Aging.

[12]  Lars Bäckman,et al.  Apolipoprotein E and cognitive performance: a meta-analysis. , 2004, Psychology and aging.

[13]  Jan Cees de Groot,et al.  Interaction Between Hypertension, apoE, and Cerebral White Matter Lesions , 2004, Stroke.

[14]  G. Alexander,et al.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Siest,et al.  The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe , 2002, European Journal of Human Genetics.

[16]  Michael Brady,et al.  Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.

[17]  R. Parasuraman,et al.  The apolipoprotein E gene, attention, and brain function. , 2002, Neuropsychology.

[18]  P. Scheltens,et al.  A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.

[19]  C. Derouesné.  [Mini-mental state examination]. , 2001, Revue neurologique.

[20]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[21]  S. Resnick,et al.  Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype , 2000, Neurology.

[22]  J. Mazziotta,et al.  Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  L. Wahlund,et al.  White Matter Lesions in Alzheimer Patients Are Influenced by Apolipoprotein E Genotype , 1999, Dementia and Geriatric Cognitive Disorders.

[24]  C. Jack,et al.  Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease , 1998, Neurology.

[25]  J. Morris,et al.  Clinical Dementia Rating: A Reliable and Valid Diagnostic and Staging Measure for Dementia of the Alzheimer Type , 1997, International Psychogeriatrics.

[26]  J. Haxby,et al.  Lack of age-related differences in temporal lobe volume of very healthy adults. , 1994, AJNR. American journal of neuroradiology.

[27]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[28]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[30]  E Capitani,et al.  Raven's coloured progressive matrices: normative values on 305 adult normal controls. , 1987, Functional neurology.

[31]  Marcella Laiacona,et al.  Tre test clinici di ricerca e produzione lessicale , 1986 .

[32]  G. Assmann,et al.  Apolipoprotein E Polymorphism and Coronary Artery Disease , 1983, Arteriosclerosis.

[33]  J. O'brien,et al.  Lipid composition of the normal human brain: gray matter, white matter, and myelin. , 1965, Journal of lipid research.

[34]  Lars T Westlye,et al.  Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4. , 2008, Neurobiology of aging.

[35]  Jim Mintz,et al.  Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. , 2006, Archives of general psychiatry.

[36]  A. Saykin,et al.  Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele. , 2006, The American journal of psychiatry.

[37]  G J Tsongalis,et al.  Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. , 2006, Neurology.

[38]  L Nyberg,et al.  Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? , 2006, Neurology.

[39]  Stephen M. Smith,et al.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.

[40]  C. Caltagirone,et al.  The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. , 1996, European neurology.